These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18390219)

  • 21. [Troponin I levels after uncomplicated, elective percutaneous coronary intervention in patients with stable coronary heart disease].
    Adamus J; Korzeniewska J; Piechota W; Olszewski R; Piechota W; Bejm J
    Pol Merkur Lekarski; 2005 Dec; 19(114):739-42. PubMed ID: 16521413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels.
    Saleh N; Braunschweig F; Jensen J; Tornvall P
    Am J Cardiol; 2006 Mar; 97(6):830-4. PubMed ID: 16516584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated troponin-I after percutaneous coronary interventions: incidence and risk factors.
    Segev A; Goldman LE; Cantor WJ; Barr A; Strauss BH; Winegard LD; Bowman KA; Chisholm RJ
    Cardiovasc Radiat Med; 2004; 5(2):59-63. PubMed ID: 15464941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
    Natarajan MK; Kreatsoulas C; Velianou JL; Mehta SR; Pericak D; Goodhart DM
    Am J Cardiol; 2004 Mar; 93(6):750-3. PubMed ID: 15019884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial damage in successful single vessel coronary angioplasty as assessed by creatinine kinase and its myocardium band isoenzyme levels.
    Abbas S; Tayyab F; Samor NA; Shabir M; Kayani AM
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):142-6. PubMed ID: 18460240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury.
    Mulukutla SR; Marroquin OC; Smith C; Varghese R; Anderson WD; Lee JS; Cohen HA; Counihan PJ; Lee AB; Gulati V; McNamara D
    Am J Cardiol; 2004 Dec; 94(11):1363-6. PubMed ID: 15566904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
    Ohlmann P; Jaquemin L; Morel O; El Behlgiti R; Faure A; Michotey MO; Beranger N; Roul G; Schneider F; Bareiss P; Monassier JP
    Am Heart J; 2006 Dec; 152(6):1161-7. PubMed ID: 17161070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial.
    McFalls EO; Ward HB; Moritz TE; Apple FS; Goldman S; Pierpont G; Larsen GC; Hattler B; Shunk K; Littooy F; Santilli S; Rapp J; Thottapurathu L; Krupski W; Reda DJ; Henderson WG
    Eur Heart J; 2008 Feb; 29(3):394-401. PubMed ID: 18245121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures.
    Salem M; Rotevatn S; Stavnes S; Brekke M; Pettersen R; Kuiper K; Ulvik R; Nordrehaug JE
    Int J Cardiol; 2005 Sep; 104(2):144-51. PubMed ID: 16168806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome.
    Saadeddin SM; Habbab MA
    Med Sci Monit; 2003 Aug; 9(8):RA193-7. PubMed ID: 12942045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
    Bjessmo S; Svenarud P; Tran PK
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes.
    Lim W; Cook DJ; Griffith LE; Crowther MA; Devereaux PJ
    Am J Crit Care; 2006 May; 15(3):280-8; quiz 289. PubMed ID: 16632770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.